Mataftsi Asimina, Malamaki Paraskevi, Prousali Efthymia, Riga Paraskevi, Lathyris Dimitrios, Chalvatzis Nikolaos T, Haidich Anna-Bettina
2nd Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Intensive Care Unit, General Hospital G. Gennimatas, Thessaloniki, Greece.
Br J Ophthalmol. 2017 Oct;101(10):1423-1430. doi: 10.1136/bjophthalmol-2016-309449. Epub 2017 Feb 27.
Although chloral hydrate (CH) has been used as a sedative for decades, it is not widely accepted as a valid choice for ophthalmic examinations in uncooperative children. This study aimed to systematically review the literature on the drug's safety and efficacy.
We searched PubMed, EMBASE, ISI Web of Science, Scopus, CENTRAL, Google Scholar and Trip database to 1 October 2015, using the keywords 'chloral hydrate', 'paediatric' and 'procedural sedation OR diagnostic sedation'. A meta-analysis of randomised controlled trials (RCTs) was performed.
A total of 6961 articles were screened and 104 were included in the review. Thirteen of these concerned paediatric ophthalmic examination, while 13 others were RCTs and were meta-analysed. CH was reported to have been administered in a total of 24 265 sedation episodes in children aged from <1 month to 18 years. The meta-analysis showed CH had a higher OR (2.95, 95% CI 1.09 to 7.99) for successful sedation compared to other sedatives, but significant limitations apply. The commonest reported adverse events (AE) were not serious (eg, paradoxical reaction or transient vomiting) and required no intervention. Severe AE, including two deaths, were related to comorbidity, overdose or aspiration.
Despite the paucity of high quality evidence, the existing literature suggests that the use of CH for procedural sedation in children appears to be an effective alternative to general anaesthesia, and it can be safe when administered in the hospital setting with appropriate monitoring and vigilance for intervention.
尽管水合氯醛(CH)作为镇静剂已使用数十年,但在不合作儿童的眼科检查中,它并未被广泛接受为有效选择。本研究旨在系统回顾关于该药物安全性和有效性的文献。
我们检索了截至2015年10月1日的PubMed、EMBASE、ISI Web of Science、Scopus、CENTRAL、谷歌学术和Trip数据库,使用关键词“水合氯醛”“儿科”和“程序性镇静或诊断性镇静”。对随机对照试验(RCT)进行了荟萃分析。
共筛选出6961篇文章,104篇纳入综述。其中13篇涉及儿科眼科检查,另外13篇为RCT并进行了荟萃分析。据报道,在年龄小于1个月至18岁的儿童中,共进行了24265次水合氯醛镇静。荟萃分析显示,与其他镇静剂相比,水合氯醛成功镇静的比值比更高(2.95,95%CI 1.09至7.99),但存在显著局限性。报告的最常见不良事件(AE)并不严重(如反常反应或短暂呕吐),无需干预。严重AE,包括两例死亡,与合并症过量或误吸有关。
尽管高质量证据匮乏,但现有文献表明,在儿童程序性镇静中使用水合氯醛似乎是全身麻醉的有效替代方法,在医院环境中进行适当监测并警惕干预时,使用该药物可能是安全的。